ArticleNature communications2025

Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficacy in mouse autoimmune models.

Janie Robert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.